CF
CORZ icon

Cantor Fitzgerald’s Core Scientific CORZ Stock Holding History

Cantor Fitzgerald’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-857,068
Closed -$12.6M – 413
2025
Q2 		$14.6M Buy
857,068
+731,068
+580% +$7.32M 0.26% 32
2025
Q1 		$912K Buy
+126,000
New +$1.43M 0.02% 120
2024
Q4 		– Sell
-116,175
Closed -$1.38M – 296
2024
Q3 		$1.38M Buy
+116,175
New +$1.2M 0.04% 65

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return

Cantor Fitzgerald's CORZ Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Core Scientific (CORZ) in Q3 2025, closing a stake of 857,068 shares — an estimated $12.6M sold.

Cantor Fitzgerald first reported a position in CORZ in Q3 2024 and held it in 3 quarters. The position peaked at $14.6M in Q2 2025. 336 funds tracked by Wall St. Rank hold CORZ as of Q3 2025.

  • Cantor Fitzgerald reported no remaining Core Scientific position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 857,068 Core Scientific shares in Q3 2025, an estimated $12.6M.
  • Cantor Fitzgerald first reported a position in Core Scientific in Q3 2024 and held it in 3 quarters.
  • Cantor Fitzgerald's Core Scientific position peaked at $14.6M in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Core Scientific as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.